Candriam SCA’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.32M | Sell |
|
|||||
|
2023
Q4 | $6.48M | Buy |
|
|||||
|
2023
Q3 | $4.66M | Sell |
|
|||||
|
2023
Q2 | $7.69M | Buy |
|
|||||
|
2023
Q1 | $6.76M | Sell |
|
|||||
|
2022
Q4 | $11.1M | Buy |
|
|||||
|
2022
Q3 | $9.57M | Buy |
|
|||||
|
2022
Q2 | $7.57M | Sell |
|
|||||
|
2022
Q1 | $13.3M | Sell |
|
|||||
|
2021
Q4 | $13.8M | Buy |
|
|||||
|
2021
Q3 | $11.5M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.42M | Hold |
|
|||||
|
2018
Q1 | $1.38M | Sell |
|
|||||
|
2017
Q4 | $2.15M | Sell |
|
|||||
|
2017
Q3 | $1.99M | Hold |
|
|||||
|
2017
Q2 | $2.53M | Sell |
|
|||||
|
2017
Q1 | $2.74M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $3.19M | Buy |
|